The World Health Organization (WHO) has dedicated this year’s World Health Day to the theme “Healthy Beginnings, Hopeful Futures,” spotlighting the urgent global need to prioritize maternal and ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

Intellectual disabilities, food allergies, and asthma were all more common in children who took multiple courses of ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar.

ShareMiss LTF has had an age long struggle with dry skin. She’s a fashion freak just like her mum and acquisition of ...

If you have atopic dermatitis (eczema), this guide will help you prepare for what to except during your initial doctor's ...

multi-target therapeutics for atopic dermatitis and other severe and common skin diseases (PRNewsfoto/Alphyn Biologics) Zabalafin Hydrogel offers the potential to be the first singular ...

Perioral dermatitis is a skin condition characterized by a rash around the mouth. It is one type of dermatitis, which is a general term for skin irritation. In the word “perioral,” “peri ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

highlighted research from the American Academy of Dermatology meeting and said his biggest takeaway from the meeting was that dermatologists are in “the decade of atopic dermatitis.” ...

Its lead product candidate, Zabalafin Hydrogel, is being developed as a topical treatment for atopic dermatitis (AD), the most common form of eczema. Zabalafin Hydrogel has demonstrated strong ...

Children with early-onset atopic dermatitis have a higher risk of developing pediatric uveitis compared to matched controls. The study found increased uveitis risk in patients untreated with dupilumab ...